HEART AND VESSELS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-08-15 ms2000000675988895

偏重的研究方向：临床研究
经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2023-01-19 ms7000001910214771 来自辽宁省

需要伦理嘛

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2022-09-17 fengli5395

目前是中科院几区呢？

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

摘要一定要描述使用的方法么？

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2015-06-16 Balance

请问Endnote选择什么参考文献的格式？谢谢！！！

364 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-28 rayms

摘要和HIGHLIGHTS的区别？

58 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-12-13 锦鹤远云心

审稿速度:3.0 | 投稿命中率:50.0
经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。

108 0

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-11-22 ms8480212230682571

9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。

102 0

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-11-04 cj18w

收版面费吗？niniya731 2016-01-11 17:16:00 发表:
审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的

niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的

150 0

[GetPortalCommentsPageByObjectIdResponse(id=1007955, encodeId=1faa100e95544, content=偏重的研究方向：临床研究 经验分享：6月15号投稿，8月3号一审建议大修后重投，8月10号大修后重新提交 8月12号审稿人意见完成 8月14号通知接受挺好的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0df5450409, createdName=ms2000000675988895, createdTime=Sun Aug 15 02:37:29 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110840, encodeId=a42d211084097, content=需要伦理嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Thu Jan 19 12:58:37 CST 2023, time=2023-01-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1250278, encodeId=549212502e867, content=目前是中科院几区呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotSA4LJMicQu1scmaYZWcmHneIHqcZ2VIg0tibx9BEyExpGEZdTZ1XiazS51KfCW73WUHtNd4KicqUQg/132, createdBy=cca02490211, createdName=fengli5395, createdTime=Sat Sep 17 15:53:15 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091046, encodeId=ebad10910466b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512574, encodeId=69a75125e4b5, content=请问Endnote选择什么参考文献的格式？谢谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=364, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97691628200, createdName=Balance, createdTime=Tue Jun 16 22:21:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091045, encodeId=88ee1091045a3, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907486, encodeId=5f3090e48689, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：18年投过一篇，审稿周期2个多月。接收后也比较快online，但是要检索到要等半年。6个月左右吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:14:13 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855191, encodeId=0e9285519180, content=9-18日投稿，10-18日一审acceptable with major revision，10-30日提交修改稿，11-12日 required reviews completed。期刊副编辑因主编接下来一周不在办公室特意来信告知，告诉11-22日给decision。果然如期收到邮件accept。整个流程3个月，效率很高，不错的杂志。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Nov 22 18:06:39 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579326, encodeId=f6f75e93265d, content=收版面费吗？niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, beContent=niniya731 2016-01-11 17:16:00 发表: 审稿一个多月，让修后重投，补充了一部分实验。修回后20多天接收。on-line还是很快的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160305/IMG56DA7847C22EC3470.jpg, createdBy=65601696308, createdName=cj18w, createdTime=Mon Nov 04 00:00:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578628, encodeId=3b4b5e8628a4, content=继续等等吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

继续等等吧

159 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务